Organogenesis Holdings (ORGO) Net Equity Issued and Repurchased (2018)
Organogenesis Holdings (ORGO) posted quarterly Net Equity Issued and Repurchased of $46.0 million for Q4 2018.
Organogenesis Holdings (ORGO) Net Equity Issued and Repurchased (2018) Analysis & Trends
Organogenesis Holdings' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $46.0 million for Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 241.91 Mn | 195.06 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 46.00 Mn |
| Dec 31, 2018 | 46.00 Mn |